Researchers identify biochemical process responsible for producing toxic tau

Alzheimer's disease
PET scan of a human brain with Alzheimer's disease. Credit: public domain

Tau is a protein that helps stabilize the internal skeleton of nerve cells (neurons) in the brain. Groups of toxic tau protein, termed tau oligomers, drive disease progression and memory loss in Alzheimer's disease (AD). A new study from Boston University School of Medicine (BUSM) shows how these tau oligomers form, and, correspondingly, how they can be prevented.

AD is a major cause of disease in the elderly and places a huge financial cost on the health care system. Scientists have known for a long time that two proteins (beta-amyloid and tau) clump and accumulate in the brains of Alzheimer patients, and this accumulation is thought to cause nerve cell injury that results in dementia.

The research in this study is based on an emerging field in biology, termed 'phase separation,' which is rooted in the discovery that proteins form droplets just like 'oil in vinegar.' "We discovered that droplets containing TIA1, an RNA binding linked to Alzheimer's disease (as well as ), provides the basis for forming the toxic tau oligomers," explained corresponding author Benjamin Wolozin, MD, Ph.D., professor of pharmacology & experimental therapeutics at BUSM.

Tau oligomers form droplets within the TIA1 droplets, and do so selectively with TIA1; other RNA binding proteins don't stimulate formation of tau droplets or tau oligomers. "This research shows that mixing tau with TIA1 produces tau oligomers that are very lethal to neurons. These results answer a fundamental question of how tau becomes toxic. It also provides a powerful tool to screen for compounds that can inhibit formation of toxic tau oligomers."

"We found that tau oligomers form droplets within the TIA1 droplets. Our research shows that mixing tau with TIA1 produces tau oligomers that are very lethal to neurons. These results answer a fundamental question of how tau becomes toxic. It also provides a powerful tool to screen for compounds that can inhibit formation of toxic tau oligomers."

The researchers generated pure proteins as a way to do the experiments in a solution containing only the specific components being studied. Then they mixed the proteins together and followed the formation of little droplets under a microscope. Surprisingly, they found that tau forms droplets within larger TIA1 droplets, but not with droplets of other proteins. They also measured the amount of toxic tau oligomers and showed that these tau in TIA1 had many toxic tau oligomers.

According to Wolozin, tau and TIA1 show up together in pathology and TIA1 is one of the few RNA binding proteins that is genetically associated with Alzheimer's disease. He believes this research can now be used to push forward drug discovery to identify compounds that prevent formation of tau oligomers.

These findings appear online in PNAS.


Explore further

Researchers describe new biology of Alzheimer's disease

More information: Peter E. A. Ash el al., "TIA1 potentiates tau phase separation and promotes generation of toxic oligomeric tau," PNAS (2021). www.pnas.org/cgi/doi/10.1073/pnas.2014188118
Citation: Researchers identify biochemical process responsible for producing toxic tau (2021, February 22) retrieved 7 March 2021 from https://medicalxpress.com/news/2021-02-biochemical-responsible-toxic-tau.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
500 shares

Feedback to editors

User comments